• Something wrong with this record ?

Prospective performance evaluation of selected common virtual screening tools. Case study: Cyclooxygenase (COX) 1 and 2

T. Kaserer, V. Temml, Z. Kutil, T. Vanek, P. Landa, D. Schuster,

. 2015 ; 96 (-) : 445-57. [pub] 20150408

Language English Country France

Document type Journal Article, Research Support, Non-U.S. Gov't

Computational methods can be applied in drug development for the identification of novel lead candidates, but also for the prediction of pharmacokinetic properties and potential adverse effects, thereby aiding to prioritize and identify the most promising compounds. In principle, several techniques are available for this purpose, however, which one is the most suitable for a specific research objective still requires further investigation. Within this study, the performance of several programs, representing common virtual screening methods, was compared in a prospective manner. First, we selected top-ranked virtual screening hits from the three methods pharmacophore modeling, shape-based modeling, and docking. For comparison, these hits were then additionally predicted by external pharmacophore- and 2D similarity-based bioactivity profiling tools. Subsequently, the biological activities of the selected hits were assessed in vitro, which allowed for evaluating and comparing the prospective performance of the applied tools. Although all methods performed well, considerable differences were observed concerning hit rates, true positive and true negative hits, and hitlist composition. Our results suggest that a rational selection of the applied method represents a powerful strategy to maximize the success of a research project, tightly linked to its aims. We employed cyclooxygenase as application example, however, the focus of this study lied on highlighting the differences in the virtual screening tool performances and not in the identification of novel COX-inhibitors.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16010260
003      
CZ-PrNML
005      
20160413102655.0
007      
ta
008      
160408s2015 fr f 000 0|engg|
009      
AR
024    7_
$a 10.1016/j.ejmech.2015.04.017 $2 doi
024    7_
$a 10.1016/j.ejmech.2015.04.017 $2 doi
035    __
$a (PubMed)25916906
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a fr
100    1_
$a Kaserer, Teresa $u Institute of Pharmacy/Pharmaceutical Chemistry and Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innrain 80-82, 6020 Innsbruck, Austria.
245    10
$a Prospective performance evaluation of selected common virtual screening tools. Case study: Cyclooxygenase (COX) 1 and 2 / $c T. Kaserer, V. Temml, Z. Kutil, T. Vanek, P. Landa, D. Schuster,
520    9_
$a Computational methods can be applied in drug development for the identification of novel lead candidates, but also for the prediction of pharmacokinetic properties and potential adverse effects, thereby aiding to prioritize and identify the most promising compounds. In principle, several techniques are available for this purpose, however, which one is the most suitable for a specific research objective still requires further investigation. Within this study, the performance of several programs, representing common virtual screening methods, was compared in a prospective manner. First, we selected top-ranked virtual screening hits from the three methods pharmacophore modeling, shape-based modeling, and docking. For comparison, these hits were then additionally predicted by external pharmacophore- and 2D similarity-based bioactivity profiling tools. Subsequently, the biological activities of the selected hits were assessed in vitro, which allowed for evaluating and comparing the prospective performance of the applied tools. Although all methods performed well, considerable differences were observed concerning hit rates, true positive and true negative hits, and hitlist composition. Our results suggest that a rational selection of the applied method represents a powerful strategy to maximize the success of a research project, tightly linked to its aims. We employed cyclooxygenase as application example, however, the focus of this study lied on highlighting the differences in the virtual screening tool performances and not in the identification of novel COX-inhibitors.
650    _2
$a cyklooxygenasa 1 $x metabolismus $7 D051545
650    _2
$a cyklooxygenasa 2 $x metabolismus $7 D051546
650    _2
$a inhibitory cyklooxygenasy $x chemie $x farmakologie $7 D016861
650    _2
$a vztah mezi dávkou a účinkem léčiva $7 D004305
650    _2
$a preklinické hodnocení léčiv $7 D004353
650    _2
$a lidé $7 D006801
650    _2
$a molekulární modely $7 D008958
650    _2
$a molekulární struktura $7 D015394
650    _2
$a vztahy mezi strukturou a aktivitou $7 D013329
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Temml, Veronika $u Institute of Pharmacy/Pharmaceutical Chemistry and Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innrain 80-82, 6020 Innsbruck, Austria.
700    1_
$a Kutil, Zsofia $u Laboratory of Plant Biotechnologies, Institute of Experimental Botany AS CR. v.v.i., Rozvojova 263, 165 02 Prague 6 - Lysolaje, Czech Republic; Department of Crop Sciences and Agroforestry, Faculty of Tropical AgriSciences, Czech University of Life Sciences Prague, Kamycka 129, 165 21 Prague 6 - Suchdol, Czech Republic.
700    1_
$a Vanek, Tomas $u Laboratory of Plant Biotechnologies, Institute of Experimental Botany AS CR. v.v.i., Rozvojova 263, 165 02 Prague 6 - Lysolaje, Czech Republic.
700    1_
$a Landa, Premysl $u Laboratory of Plant Biotechnologies, Institute of Experimental Botany AS CR. v.v.i., Rozvojova 263, 165 02 Prague 6 - Lysolaje, Czech Republic.
700    1_
$a Schuster, Daniela $u Institute of Pharmacy/Pharmaceutical Chemistry and Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innrain 80-82, 6020 Innsbruck, Austria. Electronic address: Daniela.Schuster@uibk.ac.at.
773    0_
$w MED00001628 $t European journal of medicinal chemistry $x 1768-3254 $g Roč. 96, č. - (2015), s. 445-57
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25916906 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20160408 $b ABA008
991    __
$a 20160413102738 $b ABA008
999    __
$a ok $b bmc $g 1113689 $s 934628
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 96 $c - $d 445-57 $e 20150408 $i 1768-3254 $m European journal of medicinal chemistry $n Eur J Med Chem $x MED00001628
LZP    __
$a Pubmed-20160408

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...